Fresenius Medical Care

Fresenius Medical Care is a provider of products and services for individuals undergoing dialysis because of chronic kidney failure, a condition that affects more than 1.89 million individuals worldwide. It has a network of 2,716 dialysis clinics in North America, Europe, Latin America, Asia-Pacific, and Africa. It offers specialty pharmacy and laboratory services and manufactures and distributes the most comprehensive line of dialysis equipment, disposable products, and renal pharmaceuticals.

The company was founded in 1996 and is headquartered in Bad Homburg, Frankfurt.

Fresenius Medical Care, established in 1912 and headquartered in Europe., specializes in Late Stage Venture, Early Stage Venture investments across Health Care, Medical, Manufacturing, Medical Device, Outsourcing, Collaboration, Biotechnology, Financial Services, Venture Capital, FinTech. The organization boasts a portfolio of 18 investments, with an average round size of $52.1M and 4 successful exits. Their recent investments include ApolloMed, VR Medical, Memo Therapeutics, Verve Ventures, redalpine. The highest investment round they participated in was $66.0B. Among their most notable exits are ApolloMed and VR Medical. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.